Title
Category
Credits
Event date
Cost
  • 1.00 Participation
$0.00
Course DescriptionIn this talk, Kaitlin Morrison, PhD discussing what an administrative letter is and when an administrative letter can be used to clarify a clinical protocol versus when a full amendment is required.  
  • 1.00 Participation
$0.00
Course DescriptionIn this talk, targeted at the CPO regulatory team, Kaitlin Morrison, PhD talks through how INDs are maintained at LCCC and the responsibilities of study team members.
  • 1.00 Participation
$0.00
Course DescriptionClaire Dees, MD, talks with Jared Weiss, MD and Carey Anders, MD, about their early experiences in running a clinical trial, including investigator-initiated clinical trials. Taking the CourseTo continue, click the button Take Course.
  • Investigator Initiated Trials
  • 1.00 Participation
$0.00
Course DescriptionIn this talk Mike Matamoros, MS, CIP and Cassie Myers, CIP take you through IRB regulations about investigational assays, using COVID-19 assays as examples. Taking the CourseTo continue, click the button Take Course.
  • Investigator Initiated Trials
  • 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through the business principles of critical paths, PERT charts and Gantt charts and how they can be used to streamline clinical trial activation.
  • 1.00 Participation
$0.00
Course DescriptionKaitlin Morrison, PhD takes you through when a correlative assay is considered an FDA regulated device and what types of devices require different levels of IRB and FDA approval.
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Psycho-oncology or psychosocial oncology is a sub-specialty of oncology that addresses the psychological, behavioral, emotional, and social issues that arise for cancer patients and their families. A cancer diagnosis, the treatments that follow, and the adverse effects of cancer treatments are all very distressing for patients. Psycho-oncology includes providers from various disciplines that work together as a team to best support the complex needs people face when struggling with cancer.
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Webinar DescriptionBrian Colwell Jensen, MD, will review the potential cardiotoxicity associated with radiation therapy, chemotherapy, and newer targeted cancer therapies.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Testicular cancer is the most common cancer in young men. We will discuss different aspects of this cancer from diagnosis, treatment options, and post-treatment survivorship.
  • Research to Practice
  • 1.00 Participation
$0.00
This lecture will review some of the new drugs recently FDA approved for management of lymphoma such as CAR-T therapy for relapsed/refractory Mantle Cell Lymphoma or follicular lymphoma. For rel/ref DLBCL, polatuzumab vedotin in combination with bendamustine and rituximab as well as tafasitamab plus lenalidomide have been approved in recent years. We will review the data and outcomes.

Pages